semaglutide and eye problems Ozempic Face: What causes it how to prevent it? Eye Condition a 'Very Rare'

Although their proposed GLP1-based pill had to be scrapped earlier this year following evidence of liver toxicity in a Phase III trial 12 , Pfizer has recently acquired Metasera, a biopharmaceutical company specialising in obesity therapeutics

Quantifying protein-protein interactions by molecular counting with mass photometry

The Binge Cycle Struggler: Those facing patterns of overeating, excessive appetite, and difficulty maintaining consistent eating habits

What is glutathione

It stimulates production of endothelial nitric oxide (NO), a potent vasodilator, leading to the relaxation of blood vessels and improved coronary blood flow (53, 54)

Nov 1: Mercks blockbuster Keytruda racked up another FDA approval Wednesday, as the company announced that the anti-PD-1 therapy is now authorizedin combination with gemcitabine and cisplatinto treat patients with locally advanced unresectable or metastatic biliary tract cancer (BTC)